News

Campinos and Iancu confirmed for IPBC Connect

USPTO and EPO chiefs join 140 other IP thought-leaders to take part in a ground-breaking event that has already attracted close to 1,000 registrations

Campinos and Iancu confirmed for IPBC Connect
Clarivate and CPA merge; Patents vital to covid-19 cure; Qualcomm seals key Huawei deal; DoJ gives Avanci green light; Medtronic’s winning IP strategy; plus much more
2 Aug 2020

Clarivate and CPA merge; Patents vital to covid-19 cure; Qualcomm seals key Huawei deal; DoJ gives Avanci green light; Medtronic’s winning IP strategy; plus much more

Get ready for the new working week with a summary of all the stories posted on the IAM platform over the past seven days

Ignore naysayers, the patent system is playing a vital role in the fight against covid-19
1 Aug 2020

Ignore naysayers, the patent system is playing a vital role in the fight against covid-19

We have learned some important IP lessons in the months since the coronavirus pandemic surged across the world; one of which is just how crucial IP itself is to finding a way out of the crisis

Latest

View all news
27 Jul 2020

Indonesia makes compulsory licensing easier as high-tech waits on key patent reform

Country paves way for possible covid-19 vaccine order, but promised protections for technology firms are taking longer than anticipated Read more

26 Jul 2020

Nobel laureate’s CAFC loss; IBM and Samsung do patent deal; Big value in narrowed claims; Major Fujitsu chip IP transfer; Apple under attack in China; plus much more

Get ready for the new working week with a summary of all the stories posted on the IAM platform over the past seven days Read more

25 Jul 2020

As IP moves up Canada’s national agenda, other countries should follow suit

Trio of initiatives shows the country means business and the risk of a global economic downturn means similar moves may also become an important part of recovery plans elsewhere Read more

20 Jul 2020

After success of early stage covid-19 vaccine trial, Oxford University's coronavirus IP policy explained

With the promising news today that a coronavirus vaccine being developed by scientists at the university is safe and triggers an immune response, we revisit our exclusive April interview with the head of Oxford's tech transfer office in which he talks about its new, expedited, approach to granting covid-related licences Read more

19 Jul 2020

Samsung acquires 500+ Nokia assets; Huawei HEVC exclusive; Big Ericsson deals up for renewal; IP’s glass ceiling fractures; Why Houlihan patent team left; plus much more

Get ready for the new working week with a summary of all the stories posted on the IAM platform over the past seven days Read more

18 Jul 2020

Why Huawei can’t count on patent licensing – at least in the US

Successful dealmaking cannot be isolated from broader political currents and that means China’s 5G champion may need to embrace more out-of-the-box IP value creation strategies Read more

15 Jul 2020

German Federal Court of Justice’s FRAND decision is a win for patent owners

In Sisvel v Haier, Germany’s highest court brought greater clarity to a number of issues surrounding the licensing of SEPs – and rights holders have reason to be satisfied Read more

12 Jul 2020

Corporate IP leaders expect budget cuts; Ex-TiVo CIPO joins IV; Foxconn + Sharp = patent heaven; USPTO deferred exam surge; Biopharma’s big China win; plus much more

Get ready for the new working week with a summary of all the stories posted on the IAM platform over the past seven days Read more

11 Jul 2020

Reporting serious allegations made against the WIPO director general was not fake news, it was essential

The agency's outgoing head Francis Gurry has hit out at media coverage of complaints made against him by his deputy, but the real problem was a total lack of transparency in how the affair was handled Read more

8 Jul 2020

Scoop on UK's No to the UPC was the most-read IAM story in H1 2020

The top 20 pieces of the first six months of the year dominated by coverage of the coronavirus pandemic Read more

7 Jul 2020

A patent's journey from IAM Market to Facebook v BlackBerry

Analysis shows that assets listed on the platform sell at a higher rate than average, while they are also litigated more often Read more

7 Jul 2020

How a platform technology patent list can expedite covid-19 vaccine research

More transparency around IP ownership in this vital area will help the development of treatments designed to tackle the coronavirus Read more

5 Jul 2020

“Why I quit as Nokia IP head”; Microsoft top patent assertion target; Major German FRAND decision; ARM’s China licensee struggle; NPE targets Zoom; plus much more

Get ready for the new working week with a summary of all the stories posted on the IAM platform over the past seven days Read more

4 Jul 2020

Facebook campaign highlights the power of brands, but activism is not risk-free

Consumers like companies that make stands and support causes. Authenticity is all, though; bandwagon jumpers will pay the price Read more

3 Jul 2020

Germany’s Supreme Court releases full judgment in key FRAND licensing case

Ruling in Sisvel v Haier clarifies issues around areas including what constitutes a “willing” licensee, obligations on implementers and the scope licensors have to vary royalty rates Read more

2 Jul 2020

SCOTUS doctrine of equivalents case refusal is good news for patent owners

Denial of cert in Eli Lilly v Hospira means that “tangential exception” will not be narrowed, but innovators must beware of pitfalls Read more

28 Jun 2020

US patent suits soar; No troll problem in Europe; China’s top IP judge wants anti-suit injunctions; Biogen loses key Tecfidera asset; The era of the mega NPE; plus much more

Get ready for the new working week with a summary of all the stories posted on the IAM platform over the past seven days Read more

26 Jun 2020

The era of the mega-NPE is upon us and that wasn't part of Big Tech's plans

Fortress’s offer for Finjan means another PIPCO is set to disappear and confirms that in the IP monetisation business it is now the giants that rule the roost Read more

21 Jun 2020

Trump’s Huawei U-turn; Panasonic in huge patent deal; AbbVie wins key Humira thicket case; Time ripe for new IV, says Rivette; Nokia’s patent power; plus much more

Get ready for the new working week with a summary of all the stories posted on the IAM platform over the past seven days Read more

20 Jun 2020

Japan’s position as a 5G follower will shape its IP policy

Scuttled plan to protect IoT industry from patent threats is a sign of anxiety over the landscape around the latest telecom standard Read more

17 Jun 2020

How IAM will bring together global IP leaders this September

Join us for IPBC Connect – best-in-class value creation strategies, coming to you from the people who know, throughout the month Read more

14 Jun 2020

World’s top patent firms named; Rare Google assertion targets Sonos; USPTO head troubled by filings fall; Fortress acquires Finjan; IP finance on the up; plus much more

Get ready for the new working week with a summary of all the stories posted on the IAM platform over the past seven days Read more

13 Jun 2020

It’s a great time to be involved in IP finance

Why you should expect an increase in patent-focused financing deals involving biotech and other life sciences companies Read more

11 Jun 2020

We name the world's top patent lawyers, attorneys, practices and firms

The 2020 edition of the IAM Patent 1000 features in-depth analysis of the markets in 48 key jurisdictions and is based on thousands of submissions, interviews and client references Read more

7 Jun 2020

Huawei's core 5G SEP lead; InterDigital nabs Nokia IP head; MPEG LA hopeful on CRISPR pool; The 368 entities with 1,000+ US patents; TiVo CIPO departs; plus much more

Get ready for the new working week with a summary of all the stories posted on the IAM platform over the past seven days Read more

6 Jun 2020

It’s time for the auto sector to speak with a more coherent voice on IP

There are numerous challenges facing OEMs, suppliers and new players which call for more coordinated action Read more

31 May 2020

IP no covid-19 vaccine barrier; Samsung’s $2.4bn annuities bill; Google, Facebook patent sprees; Chinese NPE crackdown call; EPO top for quality, USPTO slips; plus much more

Get ready for the new working week with a summary of all the stories posted on the IAM platform over the past seven days Read more

30 May 2020

Politics look set to trump patents in China’s coronavirus vaccine effort

Remarks made by Xi Jinping suggest that if a Chinese company develops a covid-19 cure, compulsory licensing’s big moment might not arrive after all Read more

26 May 2020

WHO covid-19 IP pool launches this week without strong pharma support

Open and global sharing of patents, data and know-how is seen as a step too far by many life sciences innovators Read more

25 May 2020

Japanese covid-19 patent pledge triples membership, but users must read fine print

Big-name electronics and chemical companies have continued to sign on, but several have taken the opportunity to narrow the terms of the pledge and remind potential infringers that they won’t tolerate abuse Read more

24 May 2020

Aon’s big IP insurance move; Huawei, Qualcomm, Samsung back new pool; US patent sales soar; Iancu covid-19 licensing exclusive; Uber patenting secrets; plus much more

Get ready for the new working week with a summary of all the stories posted on the IAM platform over the past seven days Read more

23 May 2020

The coronavirus has ended all hope of US patent eligibility reform

Opponents of stronger laws have seized the opportunity created by the pandemic to build a narrative that will make legislative changes to the 101 regime almost impossible to secure Read more

22 May 2020

Iancu on new USPTO licensing platform – “IP will play critically important role in fighting pandemic”

The agency's Patents 4 Partnerships initiative is designed to help rights owners make relevant assets available in fight against covid-19 Read more

21 May 2020

Global calls for compulsory covid-19 patent licensing build

Scrutiny of biopharma innovators’ coronavirus IP strategies will continue to intensify in coming months as concerns mount about access to treatments Read more

20 May 2020

From the archive – Japan’s patent story

A look into the IAM back catalogue to see how we have covered the developing face of IP strategy in one of the world's great innovation powers Read more

View all news